Correlation Between BioGaia AB and Xbrane Biopharma
Can any of the company-specific risk be diversified away by investing in both BioGaia AB and Xbrane Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioGaia AB and Xbrane Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioGaia AB and Xbrane Biopharma AB, you can compare the effects of market volatilities on BioGaia AB and Xbrane Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioGaia AB with a short position of Xbrane Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioGaia AB and Xbrane Biopharma.
Diversification Opportunities for BioGaia AB and Xbrane Biopharma
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between BioGaia and Xbrane is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding BioGaia AB and Xbrane Biopharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xbrane Biopharma and BioGaia AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioGaia AB are associated (or correlated) with Xbrane Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xbrane Biopharma has no effect on the direction of BioGaia AB i.e., BioGaia AB and Xbrane Biopharma go up and down completely randomly.
Pair Corralation between BioGaia AB and Xbrane Biopharma
Assuming the 90 days trading horizon BioGaia AB is expected to generate 0.4 times more return on investment than Xbrane Biopharma. However, BioGaia AB is 2.53 times less risky than Xbrane Biopharma. It trades about 0.06 of its potential returns per unit of risk. Xbrane Biopharma AB is currently generating about -0.28 per unit of risk. If you would invest 10,400 in BioGaia AB on August 29, 2024 and sell it today you would earn a total of 180.00 from holding BioGaia AB or generate 1.73% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
BioGaia AB vs. Xbrane Biopharma AB
Performance |
| Timeline |
| BioGaia AB |
| Xbrane Biopharma |
BioGaia AB and Xbrane Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioGaia AB and Xbrane Biopharma
The main advantage of trading using opposite BioGaia AB and Xbrane Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioGaia AB position performs unexpectedly, Xbrane Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xbrane Biopharma will offset losses from the drop in Xbrane Biopharma's long position.| BioGaia AB vs. Biotage AB | BioGaia AB vs. CellaVision AB | BioGaia AB vs. Sectra AB | BioGaia AB vs. Elekta AB |
| Xbrane Biopharma vs. Hansa Biopharma AB | Xbrane Biopharma vs. Vicore Pharma Holding | Xbrane Biopharma vs. XSpray Pharma AB | Xbrane Biopharma vs. Saniona AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |